Voyager Therapeutics, Inc.
USD3.58
-0.01 (-0.28%)
CEO
Alfred W. Sandrock Jr.
IPO Date
2015-11-11
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$3.58
Prev. Close
$3.59
Day Low
$3.52
Day High
$3.72
52W Low
$2.88
52W High
$5.55
Market Cap
$0.22B
Volume
0.65M
| 30,000 |
| $3.43 |
| 11 Jun 2026 | Hyman Steven | director | A-Award | Acquired | 30,000 | $3.43 |
| 11 Jun 2026 | Vitale Nancy | director | A-Award | Acquired | 30,000 | $3.43 |
| 11 Jun 2026 | Higgins Michael J | director | A-Award | Acquired | 30,000 | $3.43 |
| 11 Jun 2026 | Onyia Jude | director | A-Award | Acquired | 30,000 | $3.43 |
| 11 Jun 2026 | GERAGHTY JAMES A | director | A-Award | Acquired | 30,000 | $3.43 |
| 11 Jun 2026 | Colon Grace | director | A-Award | Acquired | 30,000 | $3.43 |
| 11 Jun 2026 | PIERCE GLENN | director | A-Award | Acquired | 30,000 | $3.43 |
| 18 May 2026 | Quinlan Amy | Principal Accounting Officer | Disposed | 0 | $0.00 |